These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1457523)

  • 1. Antimetabolites.
    Chen AP; Grem JL
    Curr Opin Oncol; 1992 Dec; 4(6):1089-98. PubMed ID: 1457523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetabolites.
    Grem JL; Chabner BA; Chu E; Johnson P; Yeh GC; Allegra CJ
    Cancer Chemother Biol Response Modif; 1991; 12():1-25. PubMed ID: 1834143
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimetabolites.
    Chu E; Johnston PG; Grem JL; Takimoto CH; Van Groeningen C; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1994; 15():1-31. PubMed ID: 7779582
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimetabolites.
    Chu E; Grem JL; Johnston PG; Politi PM; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1992; 13():1-30. PubMed ID: 1389906
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.
    Ellims PH
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):1-6. PubMed ID: 6186411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ; Otter GM; Stock CC
    Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin.
    Newman EM; Lu Y; Kashani-Sabet M; Kesavan V; Scanlon KJ
    Biochem Pharmacol; 1988 Feb; 37(3):443-7. PubMed ID: 3337743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical studies on nucleoside analogs as antitumor agents.
    Burchenal JH; Currie VE; Dowling MD; Fox JJ; Krakoff IH
    Ann N Y Acad Sci; 1975 Aug; 255():202-12. PubMed ID: 1059355
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic drug monitoring of antimetabolic cytotoxic drugs.
    Lennard L
    Br J Clin Pharmacol; 1999 Feb; 47(2):131-43. PubMed ID: 10190647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimetabolites.
    Chu E; Johnston PG; Takimoto CH; Politi PM; Grem JL; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1993; 14():1-25. PubMed ID: 8312100
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical resistance to antimetabolites.
    Spears CP
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):397-413. PubMed ID: 7642470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy: the interaction of methotrexate and 5-fluorouracil.
    Tattersall MH; Jackson RC; Connors TA; Harrap KR
    Eur J Cancer (1965); 1973 Oct; 9(10):733-9. PubMed ID: 4529730
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selective tumour chemotherapy using oncobiograms (author's transl)].
    Volm M; Kaufmann M; Wayss K; Goerttler K; Mattern J
    Dtsch Med Wochenschr; 1974 Jan; 99(2):38-43. PubMed ID: 4129485
    [No Abstract]   [Full Text] [Related]  

  • 15. [Colorectal carcinogenesis, tumor progression and chemoresistance].
    Veyrac M
    Gastroenterol Clin Biol; 1990; 14(12 ( Pt 2)):20D-24D. PubMed ID: 2073992
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.
    Sohn KJ; Croxford R; Yates Z; Lucock M; Kim YI
    J Natl Cancer Inst; 2004 Jan; 96(2):134-44. PubMed ID: 14734703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells.
    Wilkoff LJ; Wilcox WS; Burdeshaw JA; Dixon GJ; Dulmadge EA
    J Natl Cancer Inst; 1967 Nov; 39(5):965-75. PubMed ID: 6071005
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymidylate synthase pharmacogenetics.
    Marsh S
    Invest New Drugs; 2005 Dec; 23(6):533-7. PubMed ID: 16267625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of solcoseryl on antitumour action and acute toxicity of some antineoplastic drugs.
    Danysz A; Sołtysiak-Pawluczuk D; Czyzewska-Szafran H; Jedrych A; Jastrzebski Z
    Drugs Exp Clin Res; 1991; 17(2):133-8. PubMed ID: 1864228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of folate-related drug targets in cancer treatment.
    Robien K; Boynton A; Ulrich CM
    Pharmacogenomics; 2005 Oct; 6(7):673-89. PubMed ID: 16207145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.